Sosa-De Antuñano D, Pineda-Pérez D, Puentes-Rosas E, Huertas-Jiménez M, De la Torre A, Macías A

Language: Spanish
References: 27
Page: 6-13
PDF size: 226.15 Kb.

ABSTRACT

Objective: To analyze the relationship between explicit policies for antiseptics handling, the presence of obsolete antiseptics and nosocomial infections prevalence in intensive care units public hospitals.
Methods: An ecological analysis was conducted involving 41 general hospitals of three public health institutions. We use linear regression to estimate the association between hospital-level nosocomial infection prevalence and existence of antiseptics policy and obsolete antiseptics presence.
Results: Adjusting by potential confounders, hospitals where had obsolete antiseptics had seven points higher prevalence of nosocomial infection (p=0.001). Those who had evidence of handling policies antiseptics had two points prevalence lower. There was high prevalence of inadequate antiseptics, particularly hydrogen peroxide (46.7%).
Conclusions: Our findings confirm that proper selection of antiseptics can lead to improved patient safety. Antiseptics obsolete, even in suitable compounds presence, correlated with higher nosocomial infection prevalence.

REFERENCES

1. Cardo D, Dennehy PH, Halverson P, Fishman N, Kohn M, Murphy CL, et al. Moving toward elimination of healthcare- associated infections: A call to action. Am J Infect Control. 2010;38:671-5.

2. World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. A systematic review of the literature [monografía en internet]. WHO, 2011 [consultado: 28 feb 2013]. Disponible en: http://www.who.int/gpsc/country_work/burden_hcai/ en/index.html

3. Rowin ME, Patel VV, Christenson JC. Pediatric intensive care unit nosocomial infections: epidemiology, sources and solutions. Crit Care Clin. 2003;19(3):473-87.

4. Christensen JS, Jensen TG, Kolmos HJ, Pedersen C, Lassen A. Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-daymortality-a hospital-based cohort study. Eur J Clin Microbiol Infect Dis. 2012; 31(10):2719-25.

5. European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe 2008 [monografía en internet]. European Centre for Disease Prevention and Control [consultado 01 mar 2013]. Disponible en: http://www.ecdc.europa.eu/ en/publications/Publications/0812_SUR_Annual_Epidemiological_ Report_2008.pdf

6. Douglas Scott II R. The direct medical costs of Healthcare- Associated Infections in U.S. Hospitals and the Benefits of Prevention [monografía en internet]. Centers for Disease Control and Prevention. 2009 [consultado 01 mar 2013]. Disponible en: http://www.cdc.gov/HAI/pdfs/hai/ Scott_CostPaper.pdf.

7. Rosenthal VD, Guzman S, Migone O, Safdar N. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control. 2005;33(3):157-61.

8. Sánchez-Velázquez LD, Ponce de León Rosales S, Rangel Frausto MS. The burden of nosocomial infection in the intensive care unit: Effects on organ failure, mortality and costs. A nested case-control study. Arch Med Res. 2006;37(3):370-5.

9. Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castañon J, Franco G, et al. Attributable cost and length of stay for patients with central venous catheterassociated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol. 2007;28(1):31-5.

10. Médecins Sans Frontières. Medicamentos esenciales: Guía práctica de su utilización, destinado a médicos, farmacéuticos, enfermeros y auxiliares sanitarios [monografía de internet]. Médecins Sans Frontières. 2010 [consultado 01 mar 2013]. Disponible en: http://apps.who.int/medicinedocs/ documents/s17080s/s17080s.pdf

11. Montecalvo MA, McKenna D, Yarrish R, Mack L, Maguire G, Haas J, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med. 2012;125(5):505-11.

12. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol. 2009;30(10):959-63.

13. World Health Organization. Model list of essential medicines, 17th list [monografía en internet]. WHO Medicines. 2011 [consultado 01 mar 2013]. Disponible en: http:// whqlibdoc.who.int/hq/2011/a95053_eng.pdf

14. Acosta-Gío E, Rueda-Patiño JL, Sánchez-Pérez L. Sporicidal activity in liquid chemical products to sterilize or high-level disinfect medical and dental instruments. Am Journal Infect Control. 2005;33:307-9.

15. Acosta-Gío E, Herrero-Farías A, Mata-Portuguez VH. El cloruro de benzalconio: inaceptable para esterilizar o desinfectar instrumental médico o dental. Salud Pública Mex. 2001;43:570-73.

16. Food and Drug Administration. Guidance for Industry and FDA Reviewers. Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/High Level Disinfectants [monografía en internet]. Rockville, MD: Center for Devices and Radiological Health, 2000 [consultado 01 mar 2013] Disponible en: http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ ucm077575.pdf

17. Diario Oficial de la Federación. Norma Oficial Mexicana NOM-045-SSA2-2005, para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales [actualizado 20 nov 2009; consultado 01 mar 2013]. Disponible en: http://www.dof.gob.mx/documentos/3896/ salud/salud.htm

18. Girard R, Comby C, Jacques D. Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison. J Infect Public Health. 2012;5(1):35-42.

19. Pileggi C, Bianco A, Flotta D, Nobile CG, Pavia M. Prevention of ventilator-associated pneumonia, mortality and all intensive care unitacquired infections by topically applied antimicrobial or antiseptic agents: a meta-analysis of randomized controlled trials in intensive care units. Crit Care. 2011;15(3):R155.

20. Johnson PD, Martin R, Burrell LJ, Grabsch EA, Kirsa SW, O’Keeffe J, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust. 2005;183(10):509-14.

21. Shiraishi T, Nakagawa Y. Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations. Dermatology. 2002;204 Suppl 1:37-41.

22. Kassakian SZ, Mermel LA, Jefferson JA, Parenteau SL, Machan JT. Impact of chlorhexidine bathing on hospitalacquired infections among general medical patients. Infect Control Hosp Epidemiol. 2011;32(3):238-43.

23. Ministerio de Salud, Gobierno de Chile. Calidad y Seguridad del Paciente – Autorización sanitaria [actualizado no disponible; consultado 2013 mar 01]. Disponible en: http://www.minsal.gob.cl/portal/url/page/minsalcl/g_ temas/g_calidad_seguridad_paciente/cysp_autorizacion_ sanitaria.html

24. Ministerio de Salud, Gobierno de Chile. Norma técnica 124 sobre programas de prevención y control de las infecciones asociadas a la salud (IAAS) [actualizado 24 oct 2011; consultado 01 mar 2013] Disponible en: http://www.minsal.gob.cl/portal/url/item/b31d48e- 6957d1fcfe04001011e0132a2.pdf

25. Organización Mundial de la Salud. Seguridad del paciente [actualizado 2013; consultado 01 mar 2013]. Disponible en: http://www.who.int/patientsafety/es/

26. Organización Mundial de la Salud. Una atención limpia es una atención más segura [actualizado 2013; consultado 01 mar 2013]. Disponible en: http://www.who.int/gpsc/es/

27. Secretaría de Salud de México. Dirección General de Calidad y Educación en Salud. Campaña Sectorial “Está en tus manos” [actualizado 29 jun 2011; consultado 01 mar 2013]. Disponible en: http://www.calidad.salud.gob.mx/ calidad/sp_esta_entus_manos.html